$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Chemical sensors based on nanohole arrays have been a subject of numerous investigations since the first report on extraordinary optical transmission (EOT) was published by Ebbesen et al. in 19981. When light impinges on periodic arrays of nanohole structures of sub-wavelength dimensions, enhanced transmission occurs at specific wavelengths. This occurs when the incident light couples with Bloch-wave surface polariton (BW-SPP) and/or localized surface plasmons (LSP)2.
The underlying physical principle exploited when biosensing with such periodic arrays is simple. Adsorption of molecules onto or near the interface of metal changes the dielectric constant of the medium in contact with the metal, in turn shifting the location of the transmission bands in the spectrum. The spectrum itself can be adjusted by nano-engineering the shape, size, and separation distance3,4,5. By design, sensors based on EOT have characteristic bands in their spectra that facilitate specific assignments6,7,8 during the investigation of molecular binding events. This is a crucial advantage over commercially available surface plasmon resonance (SPR) platforms.
Sensors using EOT typically involve a light source optically aligned such that a collimated beam is incident on the sensing surface. Techniques to generate large nanohole surfaces, such as co-polymer templates and interference and nanosphere lithography, have poor reproducibility9. Due to these limitations in accurately fabricating large surfaces that show the EOT phenomenon, an optical microscope was required to correctly position the light source and detector. To simplify the technique, high-quality nanoimprinting lithography (NIL)10 was employed. This enabled the production of large sensor surface areas11 (mm-scale), removing the need for a microscope to look for the sensing surface on a chip. Instead, this sensor could be easily interfaced with a standard fiber optic cable.
Since the transmission peaks for this nanohole array are contained in the visible to near-infrared region (NIR), it is perfectly suited to sensing binding events for biomolecules in an aqueous environment. The expected optical behavior of the nanohole array was simulated. The result was then verified through studies with liquids of standard refractive indexes (RI). This array was then used to measure the concentration of cardiac troponin I (cTnI) in the complex background of human serum. cTnI is the clinical gold standard for the diagnosis of acute myocardial infarction.
Using this sensor, it is possible to detect and quantify cTnI in human serum at a limit of detection (LOD) of 0.55 ng/mL, which is clinically relevant. The detection is much quicker than the most commonly used technology in this domain, enzyme-linked immunosorbent assay (ELISA). Furthermore, the sensing surface can easily be regenerated and therefore reused. Hence, this work demonstrates the promise of nanohole arrays as a viable point-of-care (POC) technology for biosensing within complex biofluids.